Your browser does not support Javascript or your Javascript is turned off. Boxxet requires Javascript to work properly.

Gap now featured on Do The Catwalk | Also visit: Molly and Jake

Boxxet Home | Log in or Register

Gap

PharmaGap Advises That NCI Test Results Are Completed and Expected to Be Provided to the Company Shortly

PR Inside (Pressemitteilung) | Tue, Oct 20

Tue, Oct 20 OTTAWA, ONTARIO -- (Marketwire) -- 10/20/09 -- PharmaGap Inc. (TSX VENTURE: GAP)(OTCBB: PHRGF) ("PharmaGap" or "the Company") advises that the results of dose-range testing of the Company's cancer drug GAP-107B8 at the United States National Cancer Institute ("NCI") can be expecte...

[Read original...]

Source: PR Inside (Pressemitteilung)

From PR Inside (Pressemitteilung):

8 article(s)

browse all top blog and news sources...

Search Gap

Also of Interest...

Do you publish a blog? If so, consider joining the Boxxet Network and see your great content showcased and rewarded! Learn more...